208 related articles for article (PubMed ID: 2262907)
21. Effects of thromboxane analog U46619 on endothelial damaged canine coronary arteries in vivo.
Bove AA; Safford RE; Brum JM; Sufan Q; Dewey JD
Prostaglandins; 1986 Nov; 32(5):665-77. PubMed ID: 3823487
[TBL] [Abstract][Full Text] [Related]
22. The effect of diltiazem, a calcium channel blocking agent, on vasoconstrictor responses to norepinephrine, serotonin and potassium depolarization in canine coronary and femoral arteries.
Mullett M; Gharaibeh M; Warltier DC; Gross GJ
Gen Pharmacol; 1983; 14(2):259-64. PubMed ID: 6840509
[TBL] [Abstract][Full Text] [Related]
23. Amplifying interactions between spasmogens in vascular smooth muscle.
MacLennan SJ; Bolofo ML; Martin GR
Biochem Soc Trans; 1993 Nov; 21(4):1145-50. PubMed ID: 8131914
[No Abstract] [Full Text] [Related]
24. Altered reactivity of coronary arteries located distal to a chronic coronary occlusion.
Rapps JA; Sturek M; Jones AW; Parker JL
Am J Physiol; 1997 Oct; 273(4):H1879-87. PubMed ID: 9362256
[TBL] [Abstract][Full Text] [Related]
25. Effects of S-dobutamine on venous blood return and organ nutrient blood flow.
Pollock GD; Bowling N; Tuttle RR; Hayes JS
J Cardiovasc Pharmacol; 1992; 20(5):742-9. PubMed ID: 1280736
[TBL] [Abstract][Full Text] [Related]
26. The effect of ethanol and serotonin on blood vessels of the rat.
Malinowska B; Pietraszek M; Chabielska E; Pawlak D; Buczko W
Pol J Pharmacol Pharm; 1990; 42(4):333-42. PubMed ID: 2097594
[TBL] [Abstract][Full Text] [Related]
27. Role of endothelium-derived relaxing factor and prostaglandins in responses of coronary arteries to thromboxane in vivo.
Szwajkun K; Lamping KG; Dole WP
Circ Res; 1990 Jun; 66(6):1729-37. PubMed ID: 2344671
[TBL] [Abstract][Full Text] [Related]
28. Vascular responses of isolated canine intermediate auricular artery to vasoactive substances.
Ito T; Chiba S
Arch Int Pharmacodyn Ther; 1984 Apr; 268(2):225-31. PubMed ID: 6587834
[TBL] [Abstract][Full Text] [Related]
29. Influence of the thromboxane-mimetic U-46619 and the prostacyclin metabolite 6-keto prostaglandin E1 on vasoconstriction induced by noradrenaline and 5-HT in rat mesenteric vasculature.
Stanton BJ; Coupar IM
Prostaglandins Leukot Essent Fatty Acids; 1988 Jul; 33(1):7-12. PubMed ID: 3186779
[TBL] [Abstract][Full Text] [Related]
30. Endothelium-dependent relaxation of coronary arteries by noradrenaline and serotonin.
Cocks TM; Angus JA
Nature; 1983 Oct 13-19; 305(5935):627-30. PubMed ID: 6621711
[TBL] [Abstract][Full Text] [Related]
31. Effect of serotonin and thromboxane A2 on blood flow through moderately well developed coronary collateral vessels.
Wright L; Homans DC; Laxson DD; Dai XZ; Bache RJ
J Am Coll Cardiol; 1992 Mar; 19(3):687-93. PubMed ID: 1538028
[TBL] [Abstract][Full Text] [Related]
32. Cocaine produces coronary artery vasoconstriction independent of an intact endothelium.
Kuhn FE; Gillis RA; Virmani R; Visner MS; Schaer GL
Chest; 1992 Aug; 102(2):581-5. PubMed ID: 1643952
[TBL] [Abstract][Full Text] [Related]
33. Enhanced contraction to noradrenaline, serotonin and nerve stimulation but normal endothelium-derived relaxing factor response in skin small arteries in human primary hypertension.
Angus JA; Jennings GL; Sudhir K
Clin Exp Pharmacol Physiol Suppl; 1992; 19():39-47. PubMed ID: 1395116
[TBL] [Abstract][Full Text] [Related]
34. Action of cocaine on norepinephrine- and calcium-induced contraction of vascular smooth muscle.
D'Agostino G; Zonta F; Dondi G; Grana E
Arch Int Pharmacodyn Ther; 1983 Mar; 262(1):89-98. PubMed ID: 6870390
[TBL] [Abstract][Full Text] [Related]
35. Contraction of bovine coronary vascular smooth muscle induced by cocaine is not mediated by norepinephrine.
Foy RA; Myles JL; Wilkerson RD
Life Sci; 1991; 49(4):299-308. PubMed ID: 2072818
[TBL] [Abstract][Full Text] [Related]
36. Effects of naftidrofuryl on adrenergic nerves, endothelium and smooth muscle in isolated canine blood vessels.
Zander JF; Aarhus LL; Katusic ZS; Rubanyi GM; Vanhoutte PM
J Pharmacol Exp Ther; 1986 Dec; 239(3):760-7. PubMed ID: 3025417
[TBL] [Abstract][Full Text] [Related]
37. Effects of the thromboxane receptor antagonist SK&F 88046 in the canine, monkey and human coronary vasculature.
Ohlstein EH; Kopia GA; Zeid RL; Valocik RW; Horohonich S; Hieble JP; Wasserman MA
Prostaglandins; 1988 Jul; 36(1):69-84. PubMed ID: 3175024
[TBL] [Abstract][Full Text] [Related]
38. Synergistic effects of LTC4 and TxA2 on coronary flow and myocardial function.
Nichols WW; Mehta JL; Thompson L; Donnelly WH
Am J Physiol; 1988 Jul; 255(1 Pt 2):H153-9. PubMed ID: 3394816
[TBL] [Abstract][Full Text] [Related]
39. In vitro modulation of primate coronary vascular muscle cell reactivity by ovarian steroid hormones.
Minshall RD; Miyagawa K; Chadwick CC; Novy MJ; Hermsmeyer K
FASEB J; 1998 Oct; 12(13):1419-29. PubMed ID: 9761786
[TBL] [Abstract][Full Text] [Related]
40. Heterogeneity of vascular smooth muscle responsiveness to lipid vasoactive mediators.
Stahl GL; Lefer AM
Blood Vessels; 1987; 24(1-2):24-30. PubMed ID: 3567363
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
